Login to Your Account



Other News To Note


Monday, January 30, 2012
• GenVec Inc., of Gaithersburg, Md., extended a research collaboration and license agreement with Novartis AG, of Basel, Switzerland, in order to fund research at GenVec through January 2013 for hearing loss and balance disorders. The companies signed the original agreement in January 2010 for up to $213.6 million in up-front and milestone payments.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription